Jonathan Rosenfeld

Jonathan Rosenfeld is a Co-Founder and CTO at Somite Therapeutics and serves as the Head of the Fundamental AI group at MIT FutureTech since February 2024. Previously, Jonathan held positions as Chief Product Officer and Head of AI at Earth Force Technologies until June 2023, and as Vice President of Data Science at C2i Genomics from July 2021 to August 2022. Jonathan completed a PhD in Artificial Intelligence and Machine Learning at MIT in July 2021, focusing on deep learning's fundamental questions and its scalability. Prior to this, Jonathan earned a Master of Science in Computer Science from MIT in July 2019.